Validation of the Neuropsychological Assessment Battery Screening Module (NAB-SM) in patients with traumatic brain injury.
David Anthony HackerChristopher A JonesTom MichaelAndrew HawkinsZoe ClowesEyrsa YasinAntonio BelliNicci O'NeillJacqueline ParnhamMichaela UstianowskiHannah WardallPublished in: Applied neuropsychology. Adult (2020)
This study cross-validates the screening module of the Neuropsychological Assessment Battery (NAB-SM) with a battery of well validated neuropsychological tests (Convergent Validity Test Battery: CVTB) in a Traumatic Brain Injury (TBI) population. Forty-four participants with "mild-complicated" to "severe" TBI were recruited from a cohort of patients attending an outpatient clinic at a UK major trauma center. The NAB-SM Total Index score and an abbreviated short-form, from which a TBI Index was derived, both showed good classification accuracy in predicting impairment as measured by the CVTB mean score. These indices also accurately identified impairment as defined by the base rate of low scores across individual CVTB indices measuring mental processing speed, working memory, memory and executive functioning. The NAB-SM and its derived TBI index therefore have significant utility as a cognitive screening tool for use in either inpatient (acute) or outpatient TBI populations.
Keyphrases
- traumatic brain injury
- working memory
- advanced non small cell lung cancer
- severe traumatic brain injury
- mild cognitive impairment
- end stage renal disease
- transcranial direct current stimulation
- ejection fraction
- attention deficit hyperactivity disorder
- newly diagnosed
- mental health
- chronic kidney disease
- primary care
- liver failure
- solid state
- deep learning
- machine learning
- prognostic factors
- early onset
- epidermal growth factor receptor
- palliative care
- peritoneal dialysis
- patient reported outcomes
- respiratory failure
- tertiary care
- aortic dissection
- extracorporeal membrane oxygenation